Literature DB >> 30004226

Recent Advances in the Medicinal Chemistry of Liver X Receptors.

Bahaa El-Dien M El-Gendy1,2, Shaimaa S Goher2, Lamees S Hegazy1, Mohamed M H Arief2, Thomas P Burris3.   

Abstract

Nuclear hormone receptors represent a large family of ligand-activated transcription factors that include steroid receptors, thyroid/retinoid receptors, and orphan receptors. Among nuclear hormone receptors, the liver X receptors have emerged as very important drug targets. These receptors regulate some of the most important metabolic functions, and they were also identified as anti-inflammatory transcription factors and regulators of the immune system. The development of drugs targeting liver X receptors continues to be a challenge, but advances in our knowledge of receptor structure and function move us forward, toward achieving this goal. This review highlights the latest advances in the development of synthetic LXR modulators in the primary literature from 2013 to 2017. In this review, we place great emphasis on the structure and function of LXRs because of their essential role in the drug design process. The structure-activity relationships of the most active and promising synthetic modulators are discussed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30004226     DOI: 10.1021/acs.jmedchem.8b00045

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

2.  Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists.

Authors:  Mohamed Shahien; Mohamed Elagawany; Sadichha Sitaula; Shaimaa S Goher; Sheryl L Burris; Ryan Sanders; Amer Avdagic; Cyrielle Billon; Lamees Hegazy; Thomas P Burris; Bahaa Elgendy
Journal:  Bioorg Chem       Date:  2020-07-07       Impact factor: 5.307

Review 3.  Cellular Signal Transductions and Their Inhibitors Derived from Deep-Sea Organisms.

Authors:  Liyan Wang; Kazuo Umezawa
Journal:  Mar Drugs       Date:  2021-04-05       Impact factor: 5.118

4.  Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs).

Authors:  Andrzej T Slominski; Tae-Kang Kim; Shariq Qayyum; Yuwei Song; Zorica Janjetovic; Allen S W Oak; Radomir M Slominski; Chander Raman; Joanna Stefan; Carlos A Mier-Aguilar; Venkatram Atigadda; David K Crossman; Andriy Golub; Yaroslav Bilokin; Edith K Y Tang; Jake Y Chen; Robert C Tuckey; Anton M Jetten; Yuhua Song
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

5.  Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer's Disease and Type 2 Diabetes.

Authors:  Manel Ben Aissa; Cutler T Lewandowski; Kiira M Ratia; Sue H Lee; Brian T Layden; Mary Jo LaDu; Gregory R J Thatcher
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-05

6.  Combining generative artificial intelligence and on-chip synthesis for de novo drug design.

Authors:  Francesca Grisoni; Berend J H Huisman; Alexander L Button; Michael Moret; Kenneth Atz; Daniel Merk; Gisbert Schneider
Journal:  Sci Adv       Date:  2021-06-11       Impact factor: 14.136

Review 7.  Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Authors:  Jianglian She; Tanwei Gu; Xiaoyan Pang; Yonghong Liu; Lan Tang; Xuefeng Zhou
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.